Global Life Sciences BPO Market Size study, By Product Type (Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing, Others), and Regional Forecasts 2022-2028

Global Life Sciences BPO Market Size study, By Product Type (Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing, Others), and Regional Forecasts 2022-2028

Global Life Sciences BPO Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Life sciences business process outsourcing (BPO) is a delegation of one or more IT-intensive business processes to an external provider for managing and administrating the selected processes based on defined and measurable performance metrics. Life sciences BPO provides a wide range of services in R&D, drug registration, and product launch through a third-party provider. The growing trend of outsourcing employed by pharma and medical device companies, the growth of the pharmaceutical industry, coupled with the increasing number of clinical studies are the primary factors burgeoning the market growth across the globe. For instance, according to Statista analysis, in 2018, the worldwide pharmaceutical sector generated a revenue of USD 1204.8 billion. Also, the amount reached 1423.5 in 2021, which is anticipated to progressively grows in the impending years. Thereby, the flourishing development of the pharmaceutical industry is accelerating global market growth. However, limited outsourcing by established companies and data safety concerns impede the growth of the market over the forecast period of 2022-2028. Also, the rising R&D spending on pharmaceutical and medical devices and the growing integration of AI and machine learning (ML) for drug discovery are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Life Sciences BPO Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the rising number of skilled professionals and continuously improving healthcare infrastructure. Whereas, Europe is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the surging demand for technologically advanced drug discovery methods, as well as growth of the pharmaceutical and medical device industry, would create lucrative growth prospects for the Life Sciences BPO Market across the European region.

Major market players included in this report are:
Accenture plc
Atos SE
Boehringer Ingelheim GmbH
Catalent, Inc.
Covance, Inc. (Labcorp)
Genpact Ltd.
ICON plc
Infosys Ltd.
Lonza Group
PAREXEL International Corp.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Pharmaceutical outsourcing
Medical devices outsourcing
Contract sales and marketing outsourcing
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Life Sciences BPO Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors



Companies Mentioned

Accenture plc
Atos SE
Boehringer Ingelheim GmbH
Catalent, Inc.
Covance, Inc. (Labcorp)
Genpact Ltd.
ICON plc
Infosys Ltd.
Lonza Group
PAREXEL International Corp.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.